Management of middle-ear effusions in children

Area of Science:

• Otolaryngology
• Pediatric Medicine
• Pharmacology

Background:

• Middle-ear effusions are common in children, often requiring surgical intervention.
• Current treatments aim to reduce the need for surgery and improve outcomes.
• Carbocisteine (Mucodyne) and a combination of triprolidine hydrochloride and pseudoephedrine hydrochloride (Actifed) were investigated.

Purpose of the Study:

• To evaluate the efficacy of Mucodyne and Actifed, alone or in combination, in preventing surgery for middle-ear effusions.
• To assess the impact of pre-operative treatment on post-surgical outcomes.
• To identify factors associated with post-surgical relapse.

Main Methods:

• A double-blind, placebo-controlled trial involving children with middle-ear effusions.
• Comparison of four treatment groups: Mucodyne, Actifed, combined Mucodyne and Actifed, and placebo.
• Assessment of surgical intervention rates, pre-operative treatment effects on ear appearance and tympanometry, and post-surgical relapse rates.

Main Results:

• No statistically significant difference was observed between groups in avoiding surgical treatment.
• Pre-operative Mucodyne treatment was associated with improved ear appearance and tympanometric function in surgically treated patients.
• Relapse after surgery occurred exclusively in patients who received placebo, Actifed, or the combination pre-operatively.

Conclusions:

• Neither Mucodyne nor Actifed, alone or combined, demonstrated a significant advantage in preventing surgery for middle-ear effusions.
• Pre-operative Mucodyne may positively influence post-surgical recovery and middle ear function.
• Actifed and combination therapy did not appear to prevent post-surgical relapse.